NYSE Content Advisory: Pre-Market update
NEW YORK, May 19, 2025 /CNW/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins.
Moody's downgraded the U.S. credit rating from Aaa to Aa1, citing persistent federal deficits and the growing challenge of refinancing U.S. debt at higher interest rates, bringing the U.S. in line with other major economies.
The downgrade is expected to push Treasury yields higher and bond prices lower, potentially impacting broader financial markets.
President Trump has urged the Federal Reserve to cut interest rates, but Chair Jerome Powell has signaled a cautious, data-driven approach, with several Fed officials scheduled to speak ahead of the next rate decision on June 18.
Opening Bell
Universal Technical Institute, Inc. (NYSE:UTI) to ring The Opening Bell in celebration of their 60th anniversary and successful North Star strategy to define the future workforce.
Closing Bell
Northpointe Bancshares, Inc. (NYSE: NPB) to ring The Closing Bell ® in celebration of their recent public offering.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Cision Canada
an hour ago
- Cision Canada
BIOREM Announces Approval of Normal Course Issuer Bid
GUELPH, ON, June 11, 2025 /CNW/ - BIOREM Inc. (TSXV: BRM) ("BIOREM" or "the Company") is pleased to announce that the TSX Venture Exchange (the "TSXV") has approved its application to implement a normal course issuer bid("NCIB") for a portion of its common shares ("Common Shares"). Biorem believes that: (1) the repurchase of Common Shares would be an effective use of its cash resources and in the best interests of Biorem and its shareholders; (2) that the current market price of its Common shares does not fully reflect their underlying value; and (3) that current market conditions provide opportunities for the Company to acquire Common Shares at attractive prices. Pursuant to the NCIB notice filed with and accepted by the TSXV, the Company has been authorized to acquire up to a maximum of 806,872 Common Shares, or approximately 5% of the currently issued and outstanding Common Shares as of June 10, 2025, for cancelation. As of June 10, 2025, Biorem had 16,137,437 Common Shares issued and outstanding and a public float of 15,235,000 Common Shares. Purchases under the NCIB will commence on or about June 16, 2025 and will terminate on the earlier of: (i) one year from such commencement; or (ii) the date on which the Company has purchased the maximum number of Shares to be acquired under the NCIB. The NCIB will be conducted on behalf of the Company by Cormark Securities Inc. (the "Broker"). The purchase and payment for the Common Shares will be made in accordance with TSXV requirements at the market price of the Common Shares at the time of acquisition, plus brokerage fees, if any, charged by the Broker. Purchases under the NCIB will be made in accordance with applicable regulatory requirements through the facilities of the TSXV. All Common Shares purchased under the NCIB will be canceled upon their purchase. The Company intends to fund the purchases out of its available resources. To the Company's knowledge, none of the officers, or other insiders of the Company, or any associate of such person, or any associate of affiliate of the Company, has any present intention to sell any Shares to the Company pursuant to the NCIB. The Company has not purchased for cancellation any of its outstanding Shares within the 12 months preceding the filing of the NCIB notice with the TSXV. Advisory Regarding Forward-looking Information This news release contains "forward-looking information" within the meaning of applicable Canadian securities laws and "forward-looking statements" (and together with "forward-looking information", "FLI") . All statements other than statements of historical fact are FLI. The use of any of the words "anticipate", "believe", "could", "estimate", "expect", "future", "intend", "may", "plan", "potential", "predict", "should", "will" and similar expressions, (including negatives thereof) are intended to identify FLI. In particular, this news release includes (without limitation) forward-looking information and statements pertaining to the anticipated benefits of the NCIB. Readers are cautioned that the foregoing list of factors is not exhaustive. Although the FLI contained in this news release are based upon assumptions which management believes to be reasonable, the Company cannot assure investors that actual results will be consistent with these forward-looking statements. With respect to FLI contained in this news release, Biorem has made assumptions regarding, among other things, the ability of the Company to achieve the benefits of the NCIB. The FLI included in this news release are made as of the date of this news release and are based on the information available to the Company at such time and, other than as required by law, Biorem disclaims any intention or obligation to update or revise any FLI, whether as a result of new information, future events, or otherwise. This news release and its contents should not be construed, under any circumstances, as investment, tax, or legal advice. About BIOREM Inc. BIOREM is a leading clean technology company that designs, manufactures and distributes a comprehensive line of high-efficiency air emissions control systems used to eliminate odors, volatile organic compounds (VOCs), and hazardous air pollutants (HAPs). With sales and manufacturing offices across the continent, a dedicated research facility, a worldwide sales representative network and more than 2.000 installed systems worldwide, Biorem offers state-of-the-art technology-based products and peace of mind for municipalities, industrial companies and their surrounding communities. Additional information on Biorem is available on our website at SOURCE Biorem Inc.
Winnipeg Free Press
an hour ago
- Winnipeg Free Press
GM to invest $4 billion to ramp up US production
Shares of General Motors rose before the opening bell after announcing plans to invest $4 billion to shift some production from Mexico to U.S. manufacturing plants as the automaker navigates tariffs that could drive prices higher. President Trump signed executive orders in April, relaxing some of his 25% tariffs on automobiles and auto parts, a significant reversal as the import taxes threatened to hurt domestic manufacturers. Automakers and independent analyses say the tariffs could raise prices, reduce sales and make U.S. production less competitive worldwide. Trump portrayed the changes as a bridge toward automakers moving more production into the United States. GM said late Tuesday that the investment will be made over the next two years and is for its gas and electric vehicles. The company will add production of the gas-powered Chevrolet Blazer and Chevrolet Equinox, which are made in Mexico, to two American plants starting in 2027. The Blazer will be produced at GM's Spring Hill, Tennessee plant, while the Equinox will be made at its Kansas City, Kansas facility. GM will also begin making gas-powered full-size SUVs and light duty pickup trucks at its Orion Township, Michigan plant, which was previously being reconfigured to make electric vehicles until demand for such cars weakened. The new investment will give GM the ability to assemble more than 2 million vehicles per year in the U.S. CEO Mary Barra said in a statement on Tuesday that GM is committed to building vehicles in the U.S. and supporting American jobs. GM has 50 U.S. manufacturing plants and parts facilities in 19 states, including 11 vehicle assembly plants. The company says that almost 1 million people in the U.S. depend on it for their livelihood, including employees, suppliers, and dealers. Monday Mornings The latest local business news and a lookahead to the coming week. Last month GM lowered its profit expectations for the year as it braces for a potential impact from auto tariffs as high as $5 billion in 2025. The automaker now foresees full-year adjusted earnings before interest and taxes in a range of $10 billion to $12.5 billion. The guidance includes a current tariff exposure of $4 billion to $5 billion. GM previously predicted 2025 adjusted EBIT between $13.7 billion and $15.7 billion. Shares of General Motors Co. rose almost 1% before the opening bell Wednesday.
Winnipeg Free Press
an hour ago
- Winnipeg Free Press
Trump hails favorable federal appeals court ruling on his sweeping tariff policy as a ‘great' win
WASHINGTON (AP) — President Donald Trump on Wednesday hailed a favorable decision by a federal appeals court over his sweeping tariff policy as a 'great' win for the United States. Trump said on his social media site that the court's decision Tuesday night to let the government keep collecting his sweeping import taxes while challenges to his signature trade policy continue on appeal means the U.S. 'can use TARIFFS to protect itself against other countries.' 'A great and important win for the U.S.,' Trump wrote. The decision by the U.S. Court of Appeals for the Federal Circuit extends a similar ruling it made after another federal court struck down the tariffs May 28, saying Trump had overstepped his authority. Noting that the challenges to Trump's tariffs raise 'issues of exceptional importance,″ the appeals court said it would expedite the case and hear arguments July 31. The case involves 10% tariffs the Republican president imposed on almost every other country in April and bigger ones he imposed and then suspended on countries with which the United States runs trade deficits. It also involves tariffs he plastered on imports from China, Canada and Mexico to pressure them to do more to stop the illegal flow of immigrants and synthetic opioids across the U.S. border. In declaring the tariffs, Trump had invoked emergency powers under a 1977 law. But a three-judge panel of the U.S. Court of International Trade ruled he had exceeded his power. That ruling from the Court of International Trade came after several lawsuits arguing Trump's tariffs exceeded his authority and left the country's trade policy dependent on his whims. The tariffs upended global trade, paralyzed businesses and spooked financial markets. Monday Mornings The latest local business news and a lookahead to the coming week. ___ Follow the AP's coverage of President Donald Trump at
